FDA
approval
· 2022-02-25
FDA Approved: DEXTROAMPHETAMINE SULFATE — Supplemental Application (Lupin Pharmaceuticals,Inc.)
Summary
The FDA approved Lupin Pharmaceuticals' supplemental application for dextroamphetamine sulfate, a generic stimulant used to treat attention-deficit/hyperactivit…
Upgrade for the full analysis, importance score, and drug timeline.
Diseases / indications
Drugs mentioned
Snippet
SUPPL AP for DEXTROAMPHETAMINE SULFATE (DEXTROAMPHETAMINE SULFATE)